2C Tech Overview
- Year Founded
-
1989
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
7
2C Tech General Information
Description
Developer of nanoparticle-based medical devices designed for the treatment of retinal degenerative conditions. The company's platform incorporates photoactive nanoparticles that convert light into electrical energy, facilitating the generation of protective growth factors in diseased retinal cells, enabling healthcare providers to address ocular diseases effectively and improve patient outcomes in ophthalmology.
Contact Information
Website
www.2ctechcorp.comCorporate Office
- 15310 Barranca Parkway
- Suite 200
- Irvine, CA 92618
- United States
Corporate Office
- 15310 Barranca Parkway
- Suite 200
- Irvine, CA 92618
- United States
2C Tech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | 01-Jan-2024 | Completed | Clinical Trials - Phase 1 | |||
| 4. Later Stage VC (Series B) | 12-Dec-2019 | Completed | Clinical Trials - Phase 1 | |||
| 3. Later Stage VC (Series B) | 28-Oct-2016 | Completed | Clinical Trials - Phase 1 | |||
| 2. Accelerator/Incubator | 01-Jun-2014 | $1M | $2.47M | Completed | Startup | |
| 1. Later Stage VC (Series A) | 19-Apr-2013 | $1.47M | $1.47M | Completed | Startup |
2C Tech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
2C Tech Patents
2C Tech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3573603-A1 | Nanoparticles for sustained ophthalmic drug delivery and methods of use | Inactive | 25-Jan-2017 | ||
| EP-3573603-A4 | Nanoparticles for sustained ophthalmic drug delivery and methods of use | Inactive | 25-Jan-2017 | ||
| US-20180207293-A1 | Nanoparticles for sustained ophthalmic drug delivery and methods of use | Inactive | 25-Jan-2017 | ||
| US-20210000972-A1 | Nanoparticles for sustained ophthalmic drug delivery and methods of use | Inactive | 25-Jan-2017 | ||
| WO-2018140580-A1 | Nanoparticles for sustained ophthalmic drug delivery and methods of use | Inactive | 25-Jan-2017 | A61K47/6929 |
2C Tech Signals
2C Tech Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CONNECT (San Diego) | Accelerator/Incubator | |||
| ExSight Ventures | Venture Capital | Minority | ||
| Hoya | Corporation | Minority | ||
| InFocus Capital Partners | Venture Capital | Minority | ||
| Mantucket Capital | Family Office | Minority |
2C Tech FAQs
-
When was 2C Tech founded?
2C Tech was founded in 1989.
-
Where is 2C Tech headquartered?
2C Tech is headquartered in Irvine, CA.
-
What is the size of 2C Tech?
2C Tech has 4 total employees.
-
What industry is 2C Tech in?
2C Tech’s primary industry is Biotechnology.
-
Is 2C Tech a private or public company?
2C Tech is a Private company.
-
What is 2C Tech’s current revenue?
The current revenue for 2C Tech is .
-
How much funding has 2C Tech raised over time?
2C Tech has raised $18.5M.
-
Who are 2C Tech’s investors?
CONNECT (San Diego), ExSight Ventures, Hoya, InFocus Capital Partners, and Mantucket Capital are 5 of 7 investors who have invested in 2C Tech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process